MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 27.12.2025
OrganiGram Holdings ROE 2011-2026 | OGI
ROE Jährlich OrganiGram Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -45.46 | -2.92 | - | - | 1.91 | - | -976.96 | -142.24 | -30.35 | -26.67 |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.91 | -976.96 | -174.67 |
ROE anderer Aktien in der Arzneimittelhersteller
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
-83.89 | - | 7.5 % | $ 6.35 M |  USA |
 |
Agile Therapeutics
AGRX
|
88.64 | - | 10.11 % | $ 58.2 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3276.74 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
431.6 | - | - | $ 754 M | USA |
 |
Catalent
CTLT
|
-28.94 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
15.26 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
37.13 | - | - | $ 28.9 M |  Irlanda |
 |
DURECT Corporation
DRRX
|
-186.86 | - | - | $ 50.1 M | USA |
 |
Alimera Sciences
ALIM
|
-43.6 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
1589.72 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-66.13 | - | - | $ 2.06 B |  France |
 |
Evoke Pharma
EVOK
|
302.08 | - | - | $ 36.6 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-8.33 | $ 3.16 | 1.28 % | $ 44.4 M | USA |
 |
Cronos Group
CRON
|
-4.28 | $ 2.58 | 0.19 % | $ 1.34 B |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-50.54 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-98.17 | - | 2.45 % | $ 38.1 M | Canada |
 |
Bausch Health Companies
BHC
|
57.93 | $ 5.73 | 0.17 % | $ 2.09 B | Canada |
 |
Harrow Health
HROW
|
-9.8 | $ 38.03 | 2.5 % | $ 1.4 B | USA |
 |
Aurora Cannabis
ACB
|
-154.42 | $ 3.53 | 1.44 % | $ 86.3 M | Canada |
 |
Canopy Growth Corporation
CGC
|
-122.76 | $ 1.09 | 0.46 % | $ 117 M | Canada |
 |
Jupiter Wellness
JUPW
|
-194.84 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
92.26 | - | 1.15 % | $ 7.11 M | USA |
 |
Sundial Growers
SNDL
|
-88.87 | $ 1.4 | 2.19 % | $ 3.37 M | Canada |
 |
Neoleukin Therapeutics
NLTX
|
-34.11 | - | - | $ 193 M | Canada |
 |
Evolus
EOLS
|
223.5 | $ 4.36 | 0.69 % | $ 281 M | USA |
 |
Emergent BioSolutions
EBS
|
-117.13 | $ 8.64 | 4.79 % | $ 442 M | USA |
 |
Tilray
TLRY
|
-43.81 | $ 6.86 | 2.08 % | $ 4.24 B | Canada |
 |
Organogenesis Holdings
ORGO
|
0.33 | $ 2.44 | 2.73 % | $ 321 M | USA |
 |
Pacira BioSciences
PCRX
|
-12.79 | $ 23.78 | -1.16 % | $ 1.1 B | USA |
 |
Veru
VERU
|
-116.97 | $ 2.37 | -0.38 % | $ 320 M | USA |
 |
PetIQ
PETQ
|
0.96 | - | 1.64 % | $ 400 M | USA |
 |
Viatris
VTRS
|
0.27 | $ 13.95 | 0.83 % | $ 16.7 B | USA |
 |
ProPhase Labs
PRPH
|
29.02 | - | - | $ 5.07 M | USA |
 |
Relmada Therapeutics
RLMD
|
-66.33 | $ 7.21 | -2.3 % | $ 285 M | USA |
 |
Assertio Holdings
ASRT
|
-32.33 | $ 18.02 | - | $ 115 M | USA |
 |
Radius Health
RDUS
|
27.81 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
-22.63 | - | -4.76 % | $ 65.3 M | USA |
 |
cbdMD
YCBD
|
-7.78 | $ 0.72 | -3.36 % | $ 3.11 M | USA |
 |
OptiNose
OPTN
|
40.97 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-17.44 | $ 1.02 | 0.99 % | $ 50.9 M | USA |
 |
PLx Pharma
PLXP
|
-129.32 | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
-96.84 | $ 8.22 | -2.03 % | $ 719 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-78.37 | $ 2.29 | -2.71 % | $ 2.84 M | USA |
 |
Zomedica Corp.
ZOM
|
-70.94 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-75.79 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-14.37 | $ 0.93 | -1.31 % | $ 33.5 M | USA |
 |
Tricida
TCDA
|
-80993.58 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
-14.02 | $ 0.63 | -3.05 % | $ 2.7 M |  China |
 |
TherapeuticsMD
TXMD
|
-2.12 | $ 2.09 | 1.96 % | $ 24.2 M | USA |